NanoTess is a values-based enterprise with a vision to "prevent unnecessary suffering through technological innovation." Our team has over 40 years of cumulative experience in material science developing innovative solutions to solve a wide variety of health-related needs. Our initial focus is on helping patients with chronic wounds like diabetic foot ulcers. Apart from our strong focus on our bottom line, NanoTess aims to ensure our products are accessible and affordable for those who need them. By focusing on patient-first solutions, we believe we can create cutting edge technologies that bring value to all stakeholders. NanoSALV is approved by Health Canada under license no. 108235 and no. 108236. NanoTess is certified as per ISO 13485:2016 / MDSAP.